Pharmatalkradio
How the CMO of Sage Therapeutics Positioned a New Indication for FDA Approval
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:37:00
- More information
Informações:
Synopsis
In this session recorded at the 7th annual Chief Medical Officer Summit, Dr Steve Kanes, Chief Medical Officer, Sage Therapeutics, discusses how a company considered as an "up and comer" in the Cambridge biotech sector navigated the development and approval of the first treatment specifically designed for postpartum depression. Learn more at theconferenceforum.org
